Orchestra BioMed Holdings, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
Orchestra BioMed Holdings, Inc. (OBIO) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $325.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $166.00K, a 10.67% increase year-over-year.
- Orchestra BioMed Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $159.00K, a 8.16% increase year-over-year.
- Orchestra BioMed Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $157.00K, a 5.37% increase year-over-year.
- Orchestra BioMed Holdings, Inc. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $153.00K, a 45.55% decline year-over-year.
- Orchestra BioMed Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $607.00K, a 7.19% decline from fiscal 2024.
- Orchestra BioMed Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $654.00K, a 3.48% increase from fiscal 2023.
- Orchestra BioMed Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $632.00K, a 10.68% increase from fiscal 2022.
- Orchestra BioMed Holdings, Inc. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $571.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $325.00K 10-Q · filed 2026-08-10 | $482.00K derived: sum of 3 quarters · filed 2026-08-10 | $635.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $159.00K 10-Q · filed 2026-05-12 | $316.00K derived: sum of 2 quarters · filed 2026-05-12 | $469.00K derived: sum of 3 quarters · filed 2026-05-12 | $619.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $310.00K derived: sum of 2 quarters · filed 2026-03-12 | $460.00K derived: sum of 3 quarters · filed 2026-08-10 | $607.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $153.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $303.00K derived: sum of 2 quarters · filed 2026-08-10 | $450.00K 10-Q · filed 2025-11-10 | $599.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $150.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $297.00K 10-Q · filed 2026-08-10 | $446.00K derived: sum of 3 quarters · filed 2026-08-10 | $727.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $147.00K 10-Q · filed 2026-05-12 | $296.00K derived: sum of 2 quarters · filed 2026-05-12 | $577.00K derived: sum of 3 quarters · filed 2026-05-12 | $747.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $430.00K derived: sum of 2 quarters · filed 2026-03-12 | $600.00K derived: sum of 3 quarters · filed 2026-03-12 | $654.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $281.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $451.00K derived: sum of 2 quarters · filed 2025-11-10 | $505.00K 10-Q · filed 2025-11-10 | $664.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $170.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $224.00K 10-Q · filed 2025-08-12 | $383.00K derived: sum of 3 quarters · filed 2025-08-12 | $543.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $54.00K 10-Q · filed 2025-05-12 | $213.00K derived: sum of 2 quarters · filed 2025-05-12 | $373.00K derived: sum of 3 quarters · filed 2025-05-12 | $531.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $319.00K derived: sum of 2 quarters · filed 2025-03-31 | $477.00K derived: sum of 3 quarters · filed 2025-03-31 | $632.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $160.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $318.00K derived: sum of 2 quarters · filed 2024-11-12 | $473.00K 10-Q · filed 2024-11-12 | $625.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $313.00K 10-Q · filed 2024-08-12 | $465.00K derived: sum of 3 quarters · filed 2024-08-12 | $615.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $155.00K 10-Q · filed 2024-05-13 | $307.00K derived: sum of 2 quarters · filed 2024-05-13 | $457.00K derived: sum of 3 quarters · filed 2024-05-13 | $594.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $302.00K derived: sum of 2 quarters · filed 2024-03-27 | $439.00K derived: sum of 3 quarters · filed 2024-03-27 | $571.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $287.00K derived: sum of 2 quarters · filed 2023-11-13 | $419.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $137.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $269.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $132.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |